US equities
|
MU
$1,047.53
▼-1.65%
NVDA
$229.21
▲+0.36%
SNDK
$1,734.73
▼-0.30%
TSLA
$357.09
▲+0.64%
INTC
$119.59
▼-0.54%
AMD
$611.68
▼-0.01%
GOOGL
$339.96
▼-1.20%
SPCX
$150.56
▼-0.20%
MU
$1,047.53
▼-1.65%
NVDA
$229.21
▲+0.36%
SNDK
$1,734.73
▼-0.30%
TSLA
$357.09
▲+0.64%
INTC
$119.59
▼-0.54%
AMD
$611.68
▼-0.01%
GOOGL
$339.96
▼-1.20%
SPCX
$150.56
▼-0.20%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Latest News about Larimar Therapeutics Inc/
Recent news which mentions Larimar Therapeutics Inc/
Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
September 16, 2022
Tickers
INNO
Tags
Carole Ben/Maimon
Greg Brown
Insurance
From
Business Journals